MAY 20, 2020
1:15 PM EDT | APAC MAY, 21 2020 5:15 PM CST
Background: Acute myeloid leukemia (AML) is a molecularly and clinically heterogeneous hematological malignancy. Despite recent advancements in the treatment of AML, approximately 50% of pat...